INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 243 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,460
+21.7%
3980.0%0.00%
Q1 2024$2,022
-15.2%
3980.0%0.00%
Q4 2023$2,384
-15.4%
3980.0%0.00%
Q3 2023$2,818
+0.6%
3980.0%0.00%
Q2 2023$2,802
-15.6%
3980.0%0.00%
-100.0%
Q1 2023$3,319
-27.4%
3980.0%0.00%0.0%
Q4 2022$4,569
-8.6%
3980.0%0.00%0.0%
Q3 2022$5,000
+25.0%
398
-0.5%
0.00%0.0%
Q2 2022$4,000
-42.9%
4000.0%0.00%0.0%
Q1 2022$7,000
+16.7%
4000.0%0.00%0.0%
Q4 2021$6,0000.0%4000.0%0.00%0.0%
Q3 2021$6,0000.0%4000.0%0.00%0.0%
Q2 2021$6,000
+50.0%
4000.0%0.00%0.0%
Q1 2021$4,000
+33.3%
4000.0%0.00%0.0%
Q4 2020$3,000
+200.0%
4000.0%0.00%
Q3 2020$1,000
-50.0%
4000.0%0.00%
Q2 2020$2,000
+100.0%
4000.0%0.00%
Q1 2020$1,0000.0%4000.0%0.00%
Q4 2019$1,0000.0%4000.0%0.00%
Q3 2019$1,000
-50.0%
4000.0%0.00%
Q2 2019$2,000
-33.3%
4000.0%0.00%
-100.0%
Q1 2019$3,0000.0%4000.0%0.00%0.0%
Q4 2018$3,0000.0%4000.0%0.00%0.0%
Q3 2018$3,000
+50.0%
4000.0%0.00%
Q2 2018$2,0000.0%4000.0%0.00%
Q1 2018$2,0004000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$50,998,00020.86%
RTW INVESTMENTS, LP 3,458,120$29,048,0007.65%
ISZO CAPITAL MANAGEMENT LP 307,366$2,582,0004.49%
DAFNA Capital Management LLC 541,128$4,545,0003.84%
RA Capital Management 3,489,795$29,314,0003.60%
EMORY UNIVERSITY 375,348$3,153,0002.98%
Ghost Tree Capital, LLC 1,500,000$12,600,0002.35%
ACUTA CAPITAL PARTNERS, LLC 920,310$7,731,0001.83%
Avoro Capital Advisors LLC 1,603,001$13,465,0001.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,085,236$25,916,0001.00%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders